Session Overview
In the midst of an addiction and mental health crisis, leading to what believe is an insurmountable loss of life, municipal, provincial, and federal governments have been weighing in on an approach to support our most vulnerable. Dr. Tanguay will review policies throughout Canada and internationally to tackle the increasing deaths from non-pharmaceutical grade fentanyl. This will include looking at first-line treatments, experimental treatments, and controversial policies.
Learning Objectives
- Demonstrate a knowledge of first-line treatments for opioid use disorder.
- Evaluate the Canada Health Act.
- Analyze the evidence for involuntary addiction treatment.
References
- Bahji, A., Leger, P., Nidumolu, A., Watts, B., Dama, S., Hamilton, A., & Tanguay, R. (2023). Effectiveness of Involuntary Treatment for Individuals With Substance Use Disorders: A Systematic Review. Canadian Journal of Addiction, 14(4), 6-18.
- Bruneau, J., Ahamad, K., Goyer, M. È., Poulin, G., Selby, P., Fischer, B., … & Wood, E. (2018). Management of opioid use disorders: a national clinical practice guideline. Cmaj, 190(9), E247-E257.
- Chase, J. (2020). The Ethics of Compulsory Treatment of Addictions Under Canadian Legislation: Restricting Freedom to Promote Long-Term Autonomy?. Canadian Journal of Addiction, 11(1), 6-13.
- Walley, A. Y., Lodi, S., Li, Y., Bernson, D., Babakhanlou‐Chase, H., Land, T., & Larochelle, M. R. (2020). Association between mortality rates and medication and residential treatment after in‐patient medically managed opioid withdrawal: a cohort analysis. Addiction, 115(8), 1496-1508.
Bio
Dr. Tanguay is a psychiatrist who completed two fellowships, one in Addiction Medicine and Pain Medicine. He is a clinical assistant professor with the departments of Psychiatry and Surgery at the Cumming School of Medicine, University of Calgary.
He is the co-chair of the internationally recognized Alberta Pain Strategy and helps lead the Alberta Virtual Pain Program implementation. He is the co-founder and co-developer of the Community Rapid Access Addiction Medicine (RAAM) clinic for AHS where he works clinically.
Dr. Tanguay is member of the Calgary Police Commission, legislated to manage the annual budget as well as to establish policies providing for efficient and effective policing. He is a director for the Alberta Association of Police Governance and the Alberta Criminal Code Review Board. He is the Co-Chair of the Western Canadian Addiction Forum and Chair of the Canadian Addiction Counsel. Dr. Tanguay has been heavily involved in health policy including helping to lead the Alberta Psychedelic Legislative Committee and the Alberta Safe Supply Legislative Committee. He was a member of the Alberta Recovery Expert Advisory Panel directly advising the Alberta Minister of Addiction and Mental Health. He was a member of the Public Health Emergencies Governance Review Panel for the Government of Alberta and was a member of the Supervised Consumption Review Committee. He also sits on the Policy Committee for the Canadian Society of Addiction medicine (CSAM) where he was a former director and for the Canadian Academy of Addiction Psychiatry (CAAP).
Dr. Tanguay has been recognized for his work and is the 2021 Royal College of Physicians and Surgeons of Canada recipient of the Early Career Leadership Award, was inducted into the University of Lethbridge Alumni Honour Society, and is a recipient of the Queen Elizabeth II Platinum Jubilee Medal.
Dr. Tanguay has presented 114 invited, plenary, and Keynote lectures on three continents speaking on policy, addiction, pain, and mental health. He has received $9,327,494 in operational and research grants. Academically, he is involved in research in trauma, addiction, chronic pain, opioids, cannabis, and psychedelics and is a member of the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research & Education at the University of Calgary.
Regina Registration
